-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Names & News
-
Laurie Fenton Ambrose
Laurie Fenton Ambrose received the 2016 James L. Mulshine, MD Leadership Award, which recognized her efforts in guiding patient advocacy and other stakeholder groups in the successful efforts to gain […]
-
Jeffrey Engelman, MD, PhD
Jeffrey Engelman has been appointed Vice President and Global Head of Oncology at the Novartis Institutes of BioMedical Research. Prior to joining Novartis, Dr. Engelman was Director of the Center for […]
-
Jean-Marie Cuillerot, MD
Jean-Marie Cuillerot has been appointed Vice President and Global Head of Clinical Development at Agenus, Inc, Lexington, US, overseeing ongoing clinical development of checkpoint targeted antibodies, including AGEN1884 targeting CTLA-4 and […]
-
Anton Berns, PhD, FAACR
Anton Berns was elected to the National Academy of Sciences (NAS). NAS membership is in recognition of distinguished and continuing achievements in original research. Dr. Berns is the Senior Group Leader […]
-
In Memoriam – Gregory A. Curt, MD
On July 31, 2016, the lung cancer and oncology research community lost a respected researcher and leader, Gregory Curt, MD, who died at the US Walter Reed National Military Medical […]
-
Stefania Vallone
Stefania Vallone has been elected President of Lung Cancer Europe (LuCE), which provides a European platform for already existing lung cancer patient advocacy groups and supports the establishment of national […]
-
Charles Swanton, MD, PhD
Charles Swanton received the Biochemical Society 2016 GSK prize in recognition of distinguished research leading to new advances in medical science. Prof. Swanton is Professor of Cancer Medicine and Chair of […]
-
Patrick Soon-Shiong, MD, FRCS (C), FACS
Patrick Soon-Shiong has been appointed Chairman of the Board of Directors of Altor BioScience Corporation. Dr. Soon- Shiong is the inventor of Abraxane, an albuminbound nanoparticle of paclitaxel approved for lung, […]
-
Suresh Senan, MRCP, FRCR, PhD
Suresh Senan received the 2016 Heine H. Hansen Award, which recognizes a lung cancer investigator who has made a special contribution to lung cancer research and education on an international […]
-
Umberto Ricardi, MD
Umberto Ricardi has been elected President- Elect of the European SocieTy for Radiotherapy & Oncology (ESTRO). Prof. Ricardi is Full Professor of Radiation Oncology and Chairman of the Radiation Oncology Department, […]